Video Experimental Relacionado
Updated: Feb 26, 2026

05:29
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
3.2K
Vías moleculares distintas que conducen a la resistencia dependiente de la dosis de temozolomida en células madre de
Hany E Marei1, Giacomo Pozzoli2,3, Alice Gaiba4
1Mansoura University, Department of Cytology and Histology at the Faculty of Veterinary Medicine, Mansoura, 35116, Egypt. hanymarei@mans.edu.eg.
Cancer cell international
|February 24, 2026
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K

